This financial contribution will enable the Catalan biotech company to advance the development of new drugs targeting therapeutic targets traditionally considered intractable, such as intrinsically di...
Read more
The University of Barcelona Science Park (PCB-UB) solidified its position as a key player in Catalonia’s research and innovation landscape, with its thriving business ecosystem continuing to attract...
Read more
A new review led by researchers at CNAG, based at the Barcelona Science Park, analyzes the current opportunities and challenges of mass spectrometry-based proteomics in the study of genetic muscle dis...
Read more
The HyperSperm technology developed by Fecundis has been shown to increase the number of embryos in a pilot clinical trial and has already led to the birth of several babies.
Read more
ALLOX has developed its own proprietary platform that integrates experimental genetics, artificial intelligence, and energy-based models to identify allosteric sites and transform them into novel ther...
Read more
The neurotechnology company INBRAIN Neuroelectronics, located in the Barcelona Science Park, has received a 4 million euro grant from the Spanish Ministry of Industry and Tourism through the PERTE Chi...
Read more
New studies emphasize how peptide-based launchers, the core of Gate2Brain‘s technological platform, are poised to revolutionize drug delivery across the blood-brain barrier.
Read more
The funding will drive two preclinical development programs for its groundbreaking drug, ACT-02—an innovative compound with potential disease-modifying properties. ACT-02 functions as an inhibitor o...
Read more
The clinical-stage biotechnology company, Gain Therapeutics, has announced the administration of the first dose to a participant with Parkinson’s disease in its phase 1b clinical trial of GT-02287, ...
Read more
The BCN Health Booster accelerator comes to a close after three years in operation with a total of 107.5 million euros in funding raised by the accelerated companies through both private (52% of the t...
Read more
Since its founding in 2017, ZYMVOL has established itself as a leader in computational enzyme discovery and design. The company collaborates with the R&D teams of some of the world’s largest compani...
Read more
The research shows that among the most adapted immune cells we find those that reside in tissues located in the first line of defense against infections. This is the case in the lung, which is the gat...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Researchers from Clínic-IDIBAPS have participated in a study publishe...
